The structure-activity relationships for a variety of adenine nucleotide analogues at P-2X- and P-2Y-purinoceptors were investigated. Compounds formed by structural modifications of the ATP molecule including substitutions of the purine ring (C2, C8, N1, and N-6-substituents, and a uridine base instead of adenine), the ribose moiety (2' and 3'-positions), and the triphosphate group (lower phosphates, bridging oxygen substitution, and cyclization) were prepared. Pharmacological activity at P-2Y-purinoceptors was assayed in the guinea pig taenia coli, endothelial cells of the rabbit aorta, smooth muscle of the rabbit mesenteric artery, and turkey erythrocyte membranes. Activity at P-2X-purinoceptors was assayed in the rabbit saphenous artery and the guinea-pig vas deferens and urinary bladder. Some of the analogues displayed selectivity, or even specificity, for either the P-2X- or the P-2Y-purinoceptors. Certain analogues displayed selectivity or specificity within the P-2X- or P-2Y-purinoceptor superfamilies, giving hints about possible subclasses. For example, 8-(6-aminohexylamino)ATP and 2',3'-isopropylidene-AMP were selective for endothelial P-2Y-purinoceptors over P-2Y-purinoceptors in the guinea pig taenia coli, rabbit aorta, and turkey erythrocytes. These compounds were both inactive at P-2X-purinoceptors. The potent agonist N-6-methyl ATP and the somewhat less potent agonist 2'-deoxy-ATP were selective for P-2Y-purinoceptors in the guinea pig taenia coli, but were inactive at P-2X-purinoceptors and the vascular P-2Y-purinoceptors. 3'-Benzylamino-3'-deoxyATP was very potent at the P-2X-purinoceptors in the guinea pig vas deferens and bladder, but not in the rabbit saphenous artery and was inactive at P-2Y receptors. These data suggest that specific compounds can be developed that can be utilized to activate putative subtypes of the P-2X- and P-2Y-purinoceptor classes. (C) 1994 Wiley-Liss, Inc.